Submitted by neurosciencenewscom7688 in health
Researchers have developed a novel weight-loss drug that combines GLP-1 with molecules targeting NMDA receptors in the brain.
Submitted by neurosciencenewscom7688 in health
Researchers have developed a novel weight-loss drug that combines GLP-1 with molecules targeting NMDA receptors in the brain.